Twenty‐six men in whom the diagnosis of prostatic carcinoma had been established recently and ten men with prostatic carcinoma in relapse after orchiectomy were administered testosterone propionate. Of the measures of tumor activity that were made the only objective alteration was in the serum acid phosphatase; however, in both groups of patients the response to testosterone was extremely variable. None of the ten men in relapse experienced complete objective remission although one man, who was preterminal, developed a remarkable subjective and partial objective remission that lasted nearly a year. Another patient received testosterone for 128 days and experienced only enlargement of the primary tumor. The authors conclude that the response to exogenous testosterone is variable and unpredictable and in certain patients in relapse may be of appreciable palliative value.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.